How drug companies are playing hardball with Australia’s PBS

Pixabay/Pexels Australia is coming under increasing pressure from international drug companies demanding higher prices for their drugs. In some cases, negotiations have broken down and companies have said they’ll withdraw their drugs from the market. In other cases, companies have said they’ll not apply for their drug to be listed on the Pharmaceutical Benefits Scheme (PBS) at all. For example, the future of some PBS drugs for multiple sclerosis has been in doubt after pricing disagreements…